Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ProGen PRP is a medical technology company specializing in the design and distribution of platelet-rich plasma (PRP) systems and regenerative medicine solutions. The company's flagship product, the ProGen PRP Advantage System, is an FDA-cleared device designed for the rapid and efficient preparation of autologous platelet-rich plasma at the point of care. Their technology focuses on optimizing platelet concentration and growth factor delivery to support tissue repair and regeneration across various clinical applications. ProGen PRP serves a diverse range of medical specialties, including orthopedics, sports medicine, dermatology, and medical aesthetics. By providing easy-to-use, high-yield concentration kits, the company enables clinicians to integrate regenerative therapies into their practice with minimal processing time.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ProGen PRP.